Skip to main content
Veterinary Medicines

NOBIVAC DHPPi

Authorised
  • Canine parvovirus, strain 154, Live
  • Canine adenovirus 2, strain Manhattan, Live
  • Canine parainfluenza virus, strain Cornell, Live
  • Canine distemper virus, strain Onderstepoort, Live

Product identification

Medicine name:
NOBIVAC DHPPi
Active substance:
  • Canine parvovirus, strain 154, Live
  • Canine adenovirus 2, strain Manhattan, Live
  • Canine parainfluenza virus, strain Cornell, Live
  • Canine distemper virus, strain Onderstepoort, Live
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Canine parvovirus, strain 154, Live
    8.40
    log10 50% tissue culture infectious dose
    /
    1.00
    50% tissue culture infectious dose
  • Canine adenovirus 2, strain Manhattan, Live
    6.50
    log10 50% tissue culture infectious dose
    /
    1.00
    50% tissue culture infectious dose
  • Canine parainfluenza virus, strain Cornell, Live
    7.00
    log10 50% tissue culture infectious dose
    /
    1.00
    50% tissue culture infectious dose
  • Canine distemper virus, strain Onderstepoort, Live
    6.00
    log10 50% tissue culture infectious dose
    /
    1.00
    50% tissue culture infectious dose
Pharmaceutical form:
  • Powder and solvent for solution for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AD04
Authorisation status:
  • Valid
Authorised in:
  • Cyprus
Available in:
  • Cyprus
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • Veterinary Services, Ministry Of Agriculture, Natural Resources And Environment
Authorisation number:
  • 14539
Date of authorisation status change: